A study from GBI Research outlines drug pricing in five European countries and how regulatory mechanisms could affect the drug and pharmaceutical packaging industries.
Reportlinker.com announces that a new market research report is available in its catalog: Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs.
The recent passage of healthcare reform legislation is by no means the end of the debate over how to overhaul the U.S. healthcare system. Indeed, the real fireworks may just be beginning.
To help industry watchers and participants stay current with the reform bill’s enormous implications across multiple sectors, law firm Foley Hoag has launched a new blog with up-to-date postings on the legal, policy, and regulatory features of the changing healthcare and life sciences landscape.
FDA finds that there is no reliable evidence showing that drugs with progesterone cause birth defects.
FDA's proposed bar code rule for prescription and OTC drugs used in hospitals aims to prevent medication errors.
A petition to FDA calls for clearer inspection policies. Until then, consumers may have to scrutinize such imported products as toothpaste.
A petition to FDA calls for clearer inspection policies. Until then, consumers may have to scrutinize such imported products as toothpaste.
Document outlines test for insulated transport packages.
A petition to FDA calls for clearer inspection policies. Until then, consumers may have to scrutinize such imported products as toothpaste.
FDA finds that there is no reliable evidence showing that drugs with progesterone cause birth defects.
A petition to FDA calls for clearer inspection policies. Until then, consumers may have to scrutinize such imported products as toothpaste.